BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 6885337)

  • 1. Genetic and epigenetic control of the pyruvate kinase isozymes in mammals.
    Marie J; Levin MJ; Simon MP; Kahn A
    Isozymes Curr Top Biol Med Res; 1983; 7():221-40. PubMed ID: 6885337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural and functional linkages between subunit interfaces in mammalian pyruvate kinase.
    Wooll JO; Friesen RH; White MA; Watowich SJ; Fox RO; Lee JC; Czerwinski EW
    J Mol Biol; 2001 Sep; 312(3):525-40. PubMed ID: 11563914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pyruvate kinase (PK) isozyme switching and genetic heterogeneity of PK deficiency].
    Kanno H
    Nihon Rinsho; 1995 May; 53(5):1213-20. PubMed ID: 7602781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Regulation of pyruvate kinase gene expression and its clinical application].
    Noguchi T
    Rinsho Byori; 1990 Aug; 38(8):868-75. PubMed ID: 2232246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Alteration of isozyme gene expression during cell differentiation and oncogenesis].
    Yamada K; Noguchi T
    Nihon Rinsho; 1995 May; 53(5):1112-8. PubMed ID: 7602764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The genetic system of the L-type pyruvate kinase forms in man. Subunit structure, interrelation and kinetic characteristics of the pyruvate kinase enzymes from erythrocytes and liver.
    Kahn A; Marie J; Garreau H; Sprengers ED
    Biochim Biophys Acta; 1978 Mar; 523(1):59-74. PubMed ID: 629993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular basis of impaired pyruvate kinase isozyme conversion in erythroid cells: a single amino acid substitution near the active site and decreased mRNA content of the R-type PK.
    Kanno H; Fujii H; Tsujino G; Miwa S
    Biochem Biophys Res Commun; 1993 Apr; 192(1):46-52. PubMed ID: 8476433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis for tumor pyruvate kinase M2 allosteric regulation and catalysis.
    Dombrauckas JD; Santarsiero BD; Mesecar AD
    Biochemistry; 2005 Jul; 44(27):9417-29. PubMed ID: 15996096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The molecular basis of canine pyruvate kinase deficiency.
    Whitney KM; Goodman SA; Bailey EM; Lothrop CD
    Exp Hematol; 1994 Aug; 22(9):866-74. PubMed ID: 7520391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human erythrocyte pyruvate kinase (L'/R-PK): production and characterization of a monoclonal antibody.
    Heinrichs M; Jacobasch G; Scheiner-Bobis K; Bertram S; Eigenbrodt E; Reinacher M
    Biomed Biochim Acta; 1987; 46(2-3):S223-8. PubMed ID: 3593302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of pyruvate kinase from the liver of a patient with aberrant erythrocyte pyruvate kinase, PK Nagasaki.
    Nakashima K; Miwa S; Fujii H; Shinohara K; Yamauchi K; Tsuji Y; Yanai M
    J Lab Clin Med; 1977 Dec; 90(6):1012-20. PubMed ID: 925478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conversion of pyruvate kinase (PK) isozymes during development of normal and PK deficient erythroblasts.
    Miwa S; Takegawa S
    Biomed Biochim Acta; 1983; 42(11-12):S242-6. PubMed ID: 6675697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allostery in rabbit pyruvate kinase: development of a strategy to elucidate the mechanism.
    Friesen RH; Castellani RJ; Lee JC; Braun W
    Biochemistry; 1998 Nov; 37(44):15266-76. PubMed ID: 9799487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of L- and M-type pyruvate kinase in human tissues.
    Tsutsumi H; Tani K; Fujii H; Miwa S
    Genomics; 1988 Jan; 2(1):86-9. PubMed ID: 2838416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular and cellular regulation of pyruvate kinase in red blood cells.
    Jacobasch G; Holzhütter H
    Haematologia (Budap); 1984; 17(2):259-66. PubMed ID: 6534831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interrelationships and functions of the pyruvate kinase isozymes and their variant forms: a review.
    Ibsen KH
    Cancer Res; 1977 Feb; 37(2):341-53. PubMed ID: 188543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fifteen novel mutations in PKLR associated with pyruvate kinase (PK) deficiency: structural implications of amino acid substitutions in PK.
    van Wijk R; Huizinga EG; van Wesel AC; van Oirschot BA; Hadders MA; van Solinge WW
    Hum Mutat; 2009 Mar; 30(3):446-53. PubMed ID: 19085939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new pyruvate kinase mutation with hyperactivity in the mouse.
    Charles DJ; Pretsch W
    Biochem Genet; 1984 Dec; 22(11-12):1103-17. PubMed ID: 6529440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the rat L-type pyruvate kinase gene from its dual erythroid- and liver-specific promoter in transgenic mice.
    Tremp GL; Boquet D; Ripoche MA; Cognet M; Lone YC; Jami J; Kahn A; Daegelen D
    J Biol Chem; 1989 Nov; 264(33):19904-10. PubMed ID: 2584201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular organization of human L' and L pyruvate kinases.
    Simon MP; Marie J; Bertrand O; Kahn A
    Biochim Biophys Acta; 1982 Dec; 709(1):1-7. PubMed ID: 6758852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.